Healthcare provider profile · identity verified

Tracie Foster

Nurse Practitioner · CENTRALIA, IL · NPI 1508258476

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	312	69
Losartan Potassium	Losartan Potassium	287	71
Levothyroxine Sodium	Levothyroxine Sodium	282	71
Atorvastatin Calcium	Atorvastatin Calcium	267	60
Sertraline Hcl	Sertraline Hcl	235	36
Omeprazole	Omeprazole	234	45
Metoprolol Tartrate	Metoprolol Tartrate	200	44
Lisinopril	Lisinopril	196	47
Metoprolol Succinate	Metoprolol Succinate	193	49
Pantoprazole Sodium	Pantoprazole Sodium	181	40
Montelukast Sodium	Montelukast Sodium	173	42
Eliquis	Apixaban	171	27
Escitalopram Oxalate	Escitalopram Oxalate	158	26
Potassium Chloride	Potassium Chloride	146	36
Rosuvastatin Calcium	Rosuvastatin Calcium	140	43
Tamsulosin Hcl	Tamsulosin Hcl	136	29
Jardiance	Empagliflozin	131	24
Metformin Hcl	Metformin Hcl	129	30
Furosemide	Furosemide	128	28
Ozempic	Semaglutide	125	21
Buspirone Hcl	Buspirone Hcl	119	29
Gabapentin	Gabapentin	119	30
Pregabalin	Pregabalin	111	24
Simvastatin	Simvastatin	111	18
Albuterol Sulfate Hfa	Albuterol Sulfate	106	38
Fluticasone Propionate	Fluticasone Propionate	101	40
Hydrochlorothiazide	Hydrochlorothiazide	101	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	95	13
Clopidogrel	Clopidogrel Bisulfate	90	22
Trazodone Hcl	Trazodone Hcl	88	19
Fluoxetine Hcl	Fluoxetine Hcl	86	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	86	20
Linzess	Linaclotide	81	19
Mounjaro	Tirzepatide	71	13
Xarelto	Rivaroxaban	71	suppressed
Ezetimibe	Ezetimibe	68	21
Prednisone	Prednisone	67	51
Carvedilol	Carvedilol	66	13
Duloxetine Hcl	Duloxetine Hcl	66	14
Bumetanide	Bumetanide	65	19
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	64	13
Metformin Hcl Er	Metformin Hcl	62	11
Nebivolol Hcl	Nebivolol Hcl	60	11
Azithromycin	Azithromycin	57	36
Januvia	Sitagliptin Phosphate	56	suppressed
Irbesartan	Irbesartan	54	12
Meloxicam	Meloxicam	54	17
Nifedipine Er	Nifedipine	51	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	14
Tresiba Flextouch U-100	Insulin Degludec	48	suppressed
Roflumilast	Roflumilast	45	11
Allopurinol	Allopurinol	44	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Famotidine	Famotidine	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	39	suppressed
Nystatin	Nystatin	38	20
Olmesartan Medoxomil	Olmesartan Medoxomil	37	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Spironolactone	Spironolactone	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	16
Atenolol	Atenolol	32	suppressed
Memantine Hcl Er	Memantine Hcl	31	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Glipizide	Glipizide	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Bupropion Hcl	Bupropion Hcl	28	suppressed
Cefuroxime	Cefuroxime Axetil	28	25
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Topiramate	Topiramate	28	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	27	25
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Midodrine Hcl	Midodrine Hcl	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	21
Fenofibrate	Fenofibrate	24	suppressed
Fentanyl	Fentanyl	24	suppressed
Methimazole	Methimazole	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Estradiol	Estradiol	20	suppressed
Glycopyrrolate	Glycopyrrolate	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Cephalexin	Cephalexin	19	suppressed
Lubiprostone	Lubiprostone	19	suppressed
Methocarbamol	Methocarbamol	19	12
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Amoxicillin	Amoxicillin	18	18
Fluconazole	Fluconazole	18	15
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Folic Acid	Folic Acid	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	12
Meclizine Hcl	Meclizine Hcl	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	12
Benazepril Hcl	Benazepril Hcl	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Xolair	Omalizumab	14	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error